Table 1.

Pharmacological VTE prophylaxis dose regimes.

Pharmacological prophylaxis dose regime	% of patients	% of patients post discharge prophylaxis	12 month VTE incidence (%)	Major bleeding complications (%)
LMWH 20 mg daily	5.3	0.7	0	0
LMWH 40 mg daily	30	16	1.2	0.7
LDUH 5000 IU twice daily	30.7	4.7	1	1.3
LDUH 5000 IU three times daily	3.3	0.7	0	0
LDUH followed by LMWH	10.7	4.7	0.2	0.7
None or inadequate LDUH	20	4	0	0.7